l-pyroglutamyl-l-histidyl-3,3-dimethylprolinamide has been researched along with avapro in 1 studies
| Studies (l-pyroglutamyl-l-histidyl-3,3-dimethylprolinamide) | Trials (l-pyroglutamyl-l-histidyl-3,3-dimethylprolinamide) | Recent Studies (post-2010) (l-pyroglutamyl-l-histidyl-3,3-dimethylprolinamide) | Studies (avapro) | Trials (avapro) | Recent Studies (post-2010) (avapro) |
|---|---|---|---|---|---|
| 138 | 7 | 2 | 1,369 | 385 | 495 |
| Protein | Taxonomy | l-pyroglutamyl-l-histidyl-3,3-dimethylprolinamide (IC50) | avapro (IC50) |
|---|---|---|---|
| Bile salt export pump | Homo sapiens (human) | 7.3067 | |
| Type-1 angiotensin II receptor | Homo sapiens (human) | 0.0099 | |
| Type-2 angiotensin II receptor | Homo sapiens (human) | 0.003 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adelson, DW; Ao, Y; Chen, A; Go, VL; Nyby, MD; Smutko, V; Tuck, ML; Wijesuriya, J; Yang, H | 1 |
1 other study(ies) available for l-pyroglutamyl-l-histidyl-3,3-dimethylprolinamide and avapro
| Article | Year |
|---|---|
Role of brainstem thyrotropin-releasing hormone-triggered sympathetic overactivation in cardiovascular mortality in type 2 diabetic Goto-Kakizaki rats.
Topics: Adrenal Glands; Angiotensin II Type 1 Receptor Blockers; Animals; Biphenyl Compounds; Blood Glucose; Blood Pressure; Brain Stem; Cardiovascular Diseases; Cisterna Magna; Diabetes Mellitus, Type 2; Heart Rate; Inflammation; Injections; Irbesartan; Male; Myocardium; NADPH Oxidase 4; NADPH Oxidases; Oxidative Stress; Pyrrolidonecarboxylic Acid; Rats; Rats, Wistar; RNA, Messenger; Sympathetic Nervous System; Tetrazoles; Thyrotropin-Releasing Hormone; Vascular Cell Adhesion Molecule-1 | 2012 |